Literature DB >> 14766861

Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples.

Fernando Chaves1, Jesus García-Martínez, Sonia de Miguel, Joaquín R Otero.   

Abstract

A total of 15 of 101 (14.8%) nasal methicillin-resistant Staphylococcus aureus (MRSA) isolates exhibited mupirocin resistance (Mup(r)) compared with 1 of 154 (0.6%) methicillin-susceptible Staphylococcus aureus isolates. A total of 14 (93%) isolates exhibiting high-level Mup(r) belonged to a single clone. Horizontal plasmid transfer and transmission of Mup(r) strains contribute to a high incidence of Mup(r) MRSA at our institution.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14766861      PMCID： PMC344449          DOI： 10.1128/JCM.42.2.822-824.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci.

Authors:  R M Anthony; A M Connor; E G Power; G L French
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

2.  Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 3.  Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.

Authors:  L A Herwaldt
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

4.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 5.  The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.

Authors:  B D Cookson
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

6.  The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital.

Authors:  J E Vasquez; E S Walker; B W Franzus; B K Overbay; D R Reagan; F A Sarubbi
Journal:  Infect Control Hosp Epidemiol       Date:  2000-07       Impact factor: 3.254

7.  Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.

Authors:  M D Kalmeijer; H Coertjens; P M van Nieuwland-Bollen; D Bogaers-Hofman; G A J de Baere; A Stuurman; A van Belkum; J A J W Kluytmans
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

8.  Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory.

Authors:  D J Geha; J R Uhl; C A Gustaferro; D H Persing
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

Authors:  Trish M Perl; Joseph J Cullen; Richard P Wenzel; M Bridget Zimmerman; Michael A Pfaller; Deborah Sheppard; Jennifer Twombley; Pamela P French; Loreen A Herwaldt
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

10.  Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains.

Authors:  T A Leski; M Gniadkowski; A Skoczyńska; E Stefaniuk; K Trzciński; W Hryniewicz
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948
View more
  12 in total

1.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

3.  Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.

Authors:  Margalida Rotger; Andrej Trampuz; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.

Authors:  Jacob S Hogue; Patricia Buttke; LoRanee E Braun; Mary P Fairchok
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

5.  Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Authors:  Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.

Authors:  Erik Bathoorn; David J Hetem; Jeriela Alphenaar; Johannes G Kusters; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

7.  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.

Authors:  Andrew E Simor; Tammy L Stuart; Lisa Louie; Christine Watt; Marianne Ofner-Agostini; Denise Gravel; Michael Mulvey; Mark Loeb; Allison McGeer; Elizabeth Bryce; Anne Matlow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

8.  The Prevalence, Genotype and Antimicrobial Susceptibility of High- and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus.

Authors:  Se Young Park; Shin Moo Kim; Seok Don Park
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

9.  The Detection of Mupirocin Resistance and Nasal Carriage of Methicillin Resistant Staphylococcus aureus among Healthcare Workers at University Hospitals of Tehran, Iran.

Authors:  Solmaz Ohadian Moghadam; Mohammad Reza Pourmand; Abolfazl Davoodabadi
Journal:  Iran J Public Health       Date:  2015-03       Impact factor: 1.429

10.  In Vitro Antimicrobial Activities of Fusidic Acid and Retapamulin against Mupirocin- and Methicillin-Resistant Staphylococcus aureus.

Authors:  Sang Hyun Park; Jin Kyung Kim; Kun Park
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.